Why the study?
Does cryoballoon ablation prevent relapse similarly to radiofrequency ablation in patients with paroxysmal atrial fibrillation?
Does cryoballoon ablation prevent relapse similarly to radiofrequency ablation in patients with paroxysmal atrial fibrillation?
Cryoballoon ablation has similar mid-term efficacy to radiofrequency ablation for paroxysmal atrial fibrillation, and its success is not compromised by pulmonary vein anatomical variants.
Answers are grounded in this paper and cite their sources.
May support comparable mid-term efficacy of cryoballoon versus radiofrequency ablation in paroxysmal AF; hypothesis-generating and leaves open randomized confirmation.
AIMS: Pulmonary vein isolation is the mainstay of treatment in catheter ablation of paroxysmal atrial fibrillation (AF). Cryoballoon ablation has been introduced more recently than radiofrequency ablation, the standard technique in most centres. Pulmonary veins frequently display anatomical variants, which may compromise the results of cryoballoon ablation. We aimed to evaluate the mid-term outcomes of cryoballoon ablation in an unselected population with paroxysmal AF from an anatomical viewpoint. METHODS AND RESULTS: Consecutive patients with paroxysmal AF who underwent a first procedure of cryoballoon ablation or radiofrequency were enrolled in this single-centre study. All patients underwent systematic standardized follow-up. Comparisons between radiofrequency and cryoballoon ablation (Arctic Front™ or Arctic Front Advance™) were performed regarding safety and efficacy endpoints, according to pulmonary vein (PV) anatomical variants. A total of 687 patients were enrolled (376 radiofrequency and 311 cryoballoon ablation). Baseline characteristics and distribution of PV anatomical variants were generally similar in the groups. After a mean follow-up of 14 ± 8 months, there was no difference in the incidence of relapse (17.0% cryoballoon ablation vs. 14.1% radiofrequency, P = 0.25). We observed no interaction of PV anatomical variants on mid-term procedural success. CONCLUSION: Our findings suggest that mid-term outcomes of cryoballoon ablation for paroxysmal AF ablation are similar to those of radiofrequency, regardless of PV anatomy. The presence of anatomical variants of PVs should not discourage the referral of patients with paroxysmal AF for cryoballoon ablation.
No takes yet. Share an insight, caveat, or question.
Khoueiry et al. (2016) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: